Charleston, S.C.-based MUSC Hollings Cancer Center researcher Wenjian Gan, PhD, received two grants totaling more than $2 million for breast cancer research.
The American Cancer Society Research Scholar Grant awarded Dr. Gan $792,000 over four years, and the National Institute of General Medical Sciences Maximizing Investigators' Research Award awarded $250,000 per year for five years.
His research focuses on understanding how post-translational modifications regulate cell signaling and genomic instability, which affects breast cancer progression. Post-translational modification is a biological process that uses enzymes to modify certain amino acids after proteins have been made. Diseases like cancer can develop if errors occur during this process.